KF

Kaithakkal Faseela

Active Director Director DIN 08860878
DIN 08860878 First appointment Sep 2020 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Kaithakkal Faseela

Data last updated:

Kaithakkal Faseela is a Director at Aspire Bio Pharma India Private Limited (since 2020). The company operates in Home Appliances. Aspire Bio Pharma India Private Limited reported revenue of ₹8.18 Cr (FY 2025).

DIN 08860878
Primary Designation Director
Industry Home Appliances
First Appointment 03 Sep 2020
Oldest Company Age 6 yrs
Largest company Aspire Bio Pharma India Private Limited · ₹8.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20202020₹8.18 Cr (FY 2025)Active

Board colleagues of Kaithakkal Faseela

Directorship timeline

Open interactive timeline →
Aspire Bio Pharma India Private Limited
Premium access

Shareholding and investment profile for Kaithakkal Faseela

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaithakkal Faseela

Kaithakkal Faseela currently holds 1 directorship: Aspire Bio Pharma India Private Limited (Director, since 03 Sep 2020, revenue ₹8.18 Cr (FY 2025)).

Kaithakkal Faseela was first appointed on 03 Sep 2020 as Director at Aspire Bio Pharma India Private Limited.

The current boards of Kaithakkal Faseela's companies include Riyas Payanattil Thiruthimmel (Aspire Bio Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available